Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,041.28
(
0.26%
)
US TECH 100
25,609.60
(
0.45%
)
Dow Jones
48,578.72
(
0.24%
)
Brent Oil
95.08
(
0.07%
)
Bitcoin
75,027.84
(
-0.20%
)
News Focus
News Focus
Post# of 405175
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TheHound

Send PM Follow Ignore
Followers 75
Posts 9956
Boards Moderated 1
Alias Born 07/17/2013

TheHound

Re: To infinity and beyond! post# 94451

Saturday, 03/14/2015 9:46:31 PM

Saturday, March 14, 2015 9:46:31 PM

Post# of 405175
So what's ur answer?


<<In that you found the 'early cohort p21 data' not impressive, what would you consider impressive p21 data? I do not know. It's complicated- more p21 may not be better for the patient. Patient response and tumor markers are easier for me to understand.>>

As always, in my opinion only. Do your own due diligence!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote